
北美血流动力学监测系统市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型(非侵入性血流动力学监测系统、微创血流动力学监测系统和侵入性血流动力学监测系统)、产品(监视器和一次性用品)和最终用户(医院、家庭护理、导管实验室和门诊护理中心)
No. of Pages: 146 | Report Code: BMIRE00028114 | Category: Life Sciences
No. of Pages: 146 | Report Code: BMIRE00028114 | Category: Life Sciences
心血管疾病患病率上升推动北美血流动力学监测系统市场增长
心血管疾病 (CVD) 每年导致全世界数百万人死亡。 CVD的主要原因是高血压、肥胖和糖尿病。根据国家慢性病预防和健康促进中心、心脏病和中风预防部门的数据,美国约有 697,000 人死于心脏病——即,每 5 人死亡就有 1 人死亡。据美国心脏协会称,到 2035 年,超过 1.3 亿人(占美国人总数的 45.1%)可能会患上某种形式的心血管疾病。血流动力学监测仪可以测量心脏病患者的心脏功能和血液循环。通过监测,医生可以测量静脉、动脉和心脏内部的血压。因此,心血管疾病的患病率不断上升,对血流动力学监测系统的需求激增。
北美血流动力学监测系统市场概况
北美血流动力学监测系统市场分为美国、加拿大和墨西哥。 2021年,美国在北美血流动力学监测系统市场中占据最大份额。北美血流动力学监测系统市场的预计增长归因于医疗支出增加、心血管疾病患病率上升以及老年人口增长等因素。
北美血流动力学监测系统市场细分
北美血液动力学监测系统市场根据类型、产品、最终用户和国家/地区进行细分。
<根据类型,北美血流动力学监测系统市场分为无创血流动力学监测系统、微创血流动力学监测系统和有创血流动力学监测系统。到 2022 年,有创血流动力学监测系统领域占据北美最大的血流动力学监测系统市场份额。
根据产品,北美血流动力学监测系统监控系统市场分为监控器和一次性产品。到2022年,一次性用品细分市场将占据更大的北美血流动力学监测系统市场份额。
根据最终用户,北美血流动力学监测系统市场分为医院、家庭护理、导管实验室和门诊护理中心。 2022年,医院细分市场占据北美血流动力学监测系统市场最大份额。
按国家划分,北美血流动力学监测系统市场分为美国、加拿大和墨西哥。 2022 年,美国在北美血流动力学监测系统市场份额中占据主导地位。
Baxter International Inc、Change Healthcare、DELTEX MEDICAL、Edwards Lifesciences Corporation、通用电气公司、Getinge Group、ICU MEDICAL INC.、国际商业机器公司、皇家飞利浦 NV、Masimo 和西门子 Healthineers AG 是北美血液动力学监测系统市场的领先公司。
Strategic insights for North America Hemodynamic Monitoring System involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 623.73 Million |
Market Size by 2028 | US$ 917.28 Million |
Global CAGR (2022 - 2028) | 6.6% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Hemodynamic Monitoring System refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Hemodynamic Monitoring System Market is valued at US$ 623.73 Million in 2022, it is projected to reach US$ 917.28 Million by 2028.
As per our report North America Hemodynamic Monitoring System Market, the market size is valued at US$ 623.73 Million in 2022, projecting it to reach US$ 917.28 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Hemodynamic Monitoring System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Hemodynamic Monitoring System Market report:
The North America Hemodynamic Monitoring System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Hemodynamic Monitoring System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Hemodynamic Monitoring System Market value chain can benefit from the information contained in a comprehensive market report.